Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 934

BillFederalHouseIn Committee
Personal Drug Importation Fairness Act of 2017
About This Bill
Committee
Latest Action · February 10, 2017
Referred to the Subcommittee on Health.
Congress
115th (2017–2019)
Introduced
February 7, 2017
Cosponsors (1)
0D 1R
View PDF ↗

Summary

Highlight any text to annotate
Personal Drug Importation Fairness Act of 2017 This bill allows a drug to be imported by a person other than the drug's manufacturer if the drug: (1) has the same active ingredients, route of administration, and strength as an approved drug; (2) may be lawfully marketed in, and is imported or reimported from, a country included on a list in this Act that the Food and Drug Administration determines has standards for ensuring drug safety and effectiveness that are at least as protective as U.S. standards; (3) is dispensed by a licensed pharmacist; (4) is shipped directly to, or is imported by, the ultimate consumer; (5) is shipped or imported in quantities that do not exceed a 90-day supply; (6) is accompanied by a copy of a valid prescription; and (7) is not a controlled substance.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.